Ocular microvascular alteration in Sjogren's syndrome treated with hydroxychloroquine: an OCTA clinical study

被引:6
|
作者
Yu, Chao [3 ,4 ]
Zou, Jie [3 ]
Ge, Qian-Min [3 ]
Liao, Xu-Lin [5 ]
Pan, Yi-Cong [3 ]
Wu, Jie-Li [6 ]
Su, Ting [6 ,7 ]
Zhang, Li-Juan [3 ]
Liang, Rong-Bin [3 ]
Shao, Yi [1 ,2 ]
机构
[1] Nanchang Univ, Dept Ophthalmol, Affiliated Hosp 1, 17 Yongwaizheng St,Donghu, Nanchang 330006, Peoples R China
[2] Nanchang Univ, Jiangxi Prov Clin Ophthalmol Inst, Affiliated Hosp 1, 17 Yongwaizheng St,Donghu, Nanchang 330006, Peoples R China
[3] Nanchang Univ, Dept Ophthalmol, Affiliated Hosp 1, Nanchang, Peoples R China
[4] Nanchang Univ, Clin Med Coll 1, Nanchang, Peoples R China
[5] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Shatin, Hong Kong, Peoples R China
[6] Xiamen Univ, Eye Inst Xiamen Univ, Sch Med, Dept Ophthalmol,Xiangan Hosp,Fujian Prov Key Lab O, Xiamen, Peoples R China
[7] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear, Boston, MA USA
关键词
hydroxychloroquine (HCQ); optical coherence tomography angiography (OCTA); retinal changes; Sjogren's syndrome; vessel density; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; RETINAL PATHOLOGY; RECOMMENDATIONS; CHLOROQUINE; THICKNESS; DIAGNOSIS; THERAPY;
D O I
10.1177/20406223231164498
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Sjogren's syndrome (SjS) is a rare autoimmune disease, and despite our knowledge of SjS, we still lack effective treatments. Chloroquine drugs used to treat autoimmune diseases are still the primary medicine for SjS but increase the risk of chloroquine retinopathy.Objectives: The objective of this study is to use Optical Coherence Tomography Angiography (OCTA) images to monitor the microvascular changes in the fundus of SjS patients after hydroxychloroquine (HCQ) treatment and the feasibility of using them as diagnostic indicators.Design: This is a retrospective observational cohort study.Methods: Twelve healthy controls (HCs group; 24 eyes), 12 SjS patients (SjS group; 24 eyes), and 12 SjS patients treated with HCQ (HCQ group; 24 eyes) were recruited. Three-dimensional OCTA images of the retina were collected, and microvascular density was calculated for each eye. OCTA image segmentation for analysis was conducted using the central wheel division method (C1-C6), hemisphere segmentation method (SR, SL, IL, and IR), and the early treatment of diabetic retinopathy study method (ETDRS) (R, S, L, and I).Results: Retinal microvascular density was significantly lower in the SjS patients compared to the HCs group (p < 0.05) and much lower in the HCQ group compared to the SjS patients (p < 0.05). The SjS and HCQ groups differed in the I, R, SR, IL, and IR regions in the superficial and deep retina and the S region in the superficial retina. The ROC curves of the relationship between the HCs and SjS groups and between the SjS and HCQ groups demonstrated good classification accuracy.Conclusion: HCQ may contribute significantly to the microvascular alteration in SjS. Microvascular alteration is a potential marker with adjunctive diagnostic value. The MIR and the OCTA images of I, IR, and C1 regions showed high accuracy in minoring the alteration.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Nontypeable Hemophilus Influenza Meningitis in a Primary Sjogren's Syndrome Patient on Hydroxychloroquine
    Yassa, Gizem
    Khan, Fahad
    Manticas, Nicholas
    Majlesi, Delaram
    Zahra, Farah
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [32] Malignant lymphoma in primary Sjogren's syndrome - A multicenter, retrospective, clinical study by the European concerted action on Sjogren's syndrome
    Voulgarelis, M
    Dafni, UG
    Isenberg, KA
    Moutsopoulos, HM
    ARTHRITIS AND RHEUMATISM, 1999, 42 (08): : 1765 - 1772
  • [33] Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren’s syndrome
    Sule Yavuz
    Esra Asfuroğlu
    Muge Bicakcigil
    Ebru Toker
    Rheumatology International, 2011, 31 : 1045 - 1049
  • [34] Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren's syndrome
    Yavuz, Sule
    Asfuroglu, Esra
    Bicakcigil, Muge
    Toker, Ebru
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (08) : 1045 - 1049
  • [35] Alterations of ocular surface gene expression in Sjogren's syndrome
    Jones, DT
    Monroy, D
    Ji, ZG
    Pflugfelder, SC
    LACRIMAL GLAND, TEAR FILM, AND DRY EYE SYNDROMES 2: BASIC SCIENCE AND CLINICAL RELEVANCE, 1998, 438 : 533 - 536
  • [36] Mouse Models of Sjogren's Syndrome with Ocular Surface Disease
    Masli, Sharmila
    Dartt, Darlene A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (23) : 1 - 19
  • [37] Advances in the treatment of ocular dryness associated with Sjogren's syndrome
    Ciurtin, Coziana
    Ostas, Anca
    Cojocaru, Viorica M.
    Walsh, Stephen B.
    Isenberg, David A.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 45 (03) : 321 - 327
  • [38] Recent advances in the management of ocular complications of Sjogren's syndrome
    Samarkos, M
    Moutsopoulos, HM
    CURRENT ALLERGY AND ASTHMA REPORTS, 2005, 5 (04) : 327 - 332
  • [39] Ocular and Systemic Morbidity in a Longitudinal Cohort of Sjogren's Syndrome
    Akpek, Esen Karamursel
    Mathews, Priya
    Hahn, Sarah
    Hessen, Michelle
    Kim, Jean
    Grader-Beck, Thomas
    Birnbaum, Julius
    Baer, Alan N.
    OPHTHALMOLOGY, 2015, 122 (01) : 56 - 61
  • [40] Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjogren Syndrome The JOQUER Randomized Clinical Trial
    Gottenberg, Jacques-Eric
    Ravaud, Philippe
    Puechal, Xavier
    Le Guern, Veronique
    Sibilia, Jean
    Goeb, Vincent
    Larroche, Claire
    Dubost, Jean-Jacques
    Rist, Stephanie
    Saraux, Alain
    Devauchelle-Pensec, Valerie
    Morel, Jacques
    Hayem, Gilles
    Hatron, Pierre
    Perdriger, Aleth
    Sene, Damien
    Zarnitsky, Charles
    Batouche, Djilali
    Furlan, Valerie
    Benessiano, Joelle
    Perrodeau, Elodie
    Seror, Raphaele
    Mariette, Xavier
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (03): : 249 - 258